Dr. Salese is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
132 S 10th St
Philadelphia, PA 19107Phone+1 215-955-8900Fax+1 215-923-3447
Education & Training
- Cooper Medical School of Rowan University/Cooper University HospitalFellowship, Gastroenterology, 2008 - 2011
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2005 - 2008
- Rutgers Robert Wood Johnson Medical SchoolClass of 2005
Certifications & Licensure
- NJ State Medical License 2008 - 2025
- PA State Medical License 2005 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Publications & Presentations
PubMed
- Early recapture of response with tofacitinib 10 mg twice daily in patients with ulcerative colitis in OCTAVE Open following dose reduction or treatment interruption in...Jessica R Allegretti, Krisztina B Gecse, Michael V Chiorean, Marjorie Argollo, Xiang Guo
Journal of Gastroenterology and Hepatology. 2024-02-01 - Impact of Concomitant Corticosteroids on Tofacitinib Induction Efficacy and Infection Rates in Ulcerative Colitis.Gary R Lichtenstein, Benjamin L Cohen, Leonardo Salese, Irene Modesto, Wenjin Wang
Digestive Diseases and Sciences. 2023-06-01 - 2 citationsClostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program.Edward V Loftus, Daniel C Baumgart, Krisztina Gecse, Jami A Kinnucan, Susan B Connelly
Inflammatory Bowel Diseases. 2023-05-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: